⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8568823 | 0.59 | — | — | |
| SCHEMBL18249460 | 0.51 | — | — | |
| SCHEMBL13673949 | 0.50 | — | — | |
| SCHEMBL7221897 | 0.41 | — | — | |
| SCHEMBL8036160 | 0.38 | — | — | |
| SCHEMBL1411737 | 0.35 | — | — | |
| SCHEMBL1772709 | 0.35 | — | — | |
| SCHEMBL3394066 | 0.32 | — | — | |
| SCHEMBL31398609 | 0.32 | — | — | |
| SCHEMBL24617 | 0.32 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9556143-B2 | Metalloenzyme inhibitor compounds | VIAMET PHARMACEUTICALS, INC. (US) | 2017-01-31 | — | — | US | disclosed |
| US-20150099750-A1 | METALLOENZYME INHIBITOR COMPOUNDS | Viamet Pharmaceuticals (NC), Inc. | 2015-04-09 | — | — | US | disclosed |